{
    "Question": "Owlet Baby Care Inc. CES 2024 product highlight and specification",
    "Summary": "Owlet Baby Care Inc.\n\nProduct: Dream Sock® and BabySat™\n\n- Dream Sock®: FDA-cleared medical pulse oximetry device for infants without a prescription, providing real-time health insights and notifications for low pulse rate, high pulse rate, and low oxygen. Equipped with the Owlet Dream App for tracking Live Health Readings.\n\n- BabySat™: FDA-cleared pulse oximetry monitoring system for infants with acute or chronic medical conditions, available through prescription only. It allows healthcare providers to set and adjust customizable alarms for oxygen saturation and pulse rate. Eligible for insurance reimbursement.\n\nBoth devices aim to empower caregivers with accurate and actionable data, enhancing infant care at home. The products are part of Owlet's commitment to providing clarity and peace of mind for parents, setting new standards in the industry of infant care.",
    "Summary_cn": "Owlet Baby Care Inc.\n产品：Dream Sock®和BabySat™\n\n- Dream Sock®：无需处方的FDA认可的婴儿医用脉搏血氧测量设备，可提供实时健康见解和通知，监测脉率低、脉率高和低氧。配备Owlet Dream App，用于跟踪实时健康读数。\n\n- BabySat™：FDA认可的脉搏血氧监测系统，适用于患有急性或慢性医疗状况的婴儿，仅可通过处方获得。它允许医疗保健提供者设置和调整可自定义的氧饱和度和脉率警报。符合保险报销条件。\n\n这两款设备旨在为护理人员提供准确可行的数据，提高家庭婴儿护理水平。这些产品是Owlet为提供明晰和安心的父母关怀而承诺的一部分，为婴儿护理行业设立新标准。"
}